Cargando…

C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo

Uncontrolled activation of the complement alternative pathway is associated with complement-mediated renal disease. Factor B and factor D are essential components of this pathway, while factor H (FH) is its major regulator. In complete FH deficiency, uncontrolled C3 activation through the alternativ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruseva, M M, Takahashi, M, Fujita, T, Pickering, M C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Ltd 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958157/ https://www.ncbi.nlm.nih.gov/pubmed/24279761 http://dx.doi.org/10.1111/cei.12244

Ejemplares similares

Mannan binding lectin-associated serine protease-2 (MASP-2) critically contributes to post-ischemic brain injury independent of MASP-1
por: Orsini, Franca, et al.
Publicado: (2016)

The complex formation of MASP-3 with pattern recognition molecules of the lectin complement pathway retains MASP-3 in the circulation
por: Kusakari, Kohei, et al.
Publicado: (2022)

Mannan-binding lectin serine protease-2 (MASP-2) in human kidney and its relevance for proteolytic activation of the epithelial sodium channel
por: Zachar, Rikke, et al.
Publicado: (2022)

MBL-associated serine proteases (MASPs) and infectious diseases
por: Beltrame, Marcia H., et al.
Publicado: (2015)

Polymorphisms in the MASP1 Gene Are Associated with Serum Levels of MASP-1, MASP-3, and MAp44
por: Gytz Ammitzbøll, Christian, et al.
Publicado: (2013)

The Serine Protease Domain of MASP-3: Enzymatic Properties and Crystal Structure in Complex with Ecotin
por: Gaboriaud, Christine, et al.
Publicado: (2013)

Progressive IgA Nephropathy Is Associated With Low Circulating Mannan-Binding Lectin–Associated Serine Protease-3 (MASP-3) and Increased Glomerular Factor H–Related Protein-5 (FHR5) Deposition
por: Medjeral-Thomas, Nicholas R., et al.
Publicado: (2017)

Pentraxin 3, ficolin-2 and lectin pathway associated serine protease MASP-3 as early predictors of myocardial infarction - the HUNT2 study
por: Vengen, Inga Thorsen, et al.
Publicado: (2017)

Cleavage of Kininogen and Subsequent Bradykinin Release by the Complement Component: Mannose-Binding Lectin-Associated Serine Protease (MASP)-1
por: Dobó, József, et al.
Publicado: (2011)

Targeting the Complement Serine Protease MASP-2 as a Therapeutic Strategy for Coronavirus Infections
por: Flude, Ben M., et al.
Publicado: (2021)

Mannose-Binding Lectin (MBL) and MBL-associated serine protease-2 (MASP-2) in women with malignant and benign ovarian tumours
por: Swierzko, Anna St., et al.
Publicado: (2014)

Should MASP-2 Deficiency Be Considered a Primary Immunodeficiency? Relevance of the Lectin Pathway
por: García-Laorden, M. Isabel, et al.
Publicado: (2019)

MASP-1 Induced Clotting – The First Model of Prothrombin Activation by MASP-1
por: Jenny, Lorenz, et al.
Publicado: (2015)

Mannose-binding lectin-associated serine protease 2 (MASP-2) contributes to poor disease outcome in humans and mice with pneumococcal meningitis
por: Kasanmoentalib, E. Soemirien, et al.
Publicado: (2017)

Association of MASP2 levels and MASP2 gene polymorphisms with systemic lupus erythematosus
por: Xu, Wang‐Dong, et al.
Publicado: (2020)

Interactions between mannose-binding lectin and MASPs during complement activation by the lectin pathway
por: Wallis, Russell
Publicado: (2007)

Erratum to: Mannose-binding lectin-associated serine protease 2 (MASP-2) contributes to poor disease outcome in humans and mice with pneumococcal meningitis
por: Kasanmoentalib, E. Soemirien, et al.
Publicado: (2017)

Fasciola hepatica is refractory to complement killing by preventing attachment of mannose binding lectin (MBL) and inhibiting MBL-associated serine proteases (MASPs) with serpins
por: De Marco Verissimo, Carolina, et al.
Publicado: (2022)

Association of MASP-2 Levels and MASP2 Gene Polymorphisms with Rheumatoid Arthritis in Patients and Their Relatives
por: Goeldner, Isabela, et al.
Publicado: (2014)

MASP-1 and MASP-2 Serum Levels Are Associated With Worse Prognostic in Cervical Cancer Progression
por: Maestri, Carlos Afonso, et al.
Publicado: (2018)

Prevalence of the polymorphic H-f icolin (FCN3) genes and mannose-binding lectin-associated serine protease-2 (MASP2) in indigenous populations from the Russian Arctic regions
por: Smolnikova, M.V., et al.
Publicado: (2021)

Lectin Pathway Enzyme MASP-2 and Downstream Complement Activation in COVID-19
por: Götz, Maximilian Peter, et al.
Publicado: (2022)

MASP-2 Is a Heparin-Binding Protease; Identification of Blocking Oligosaccharides
por: Talsma, Ditmer T., et al.
Publicado: (2020)

MASP-1 Increases Endothelial Permeability
por: Debreczeni, Márta L., et al.
Publicado: (2019)

Mutations in the lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndrome
por: Rooryck, Caroline, et al.
Publicado: (2011)

Synergy of protease-binding sites within the ecotin homodimer is crucial for inhibition of MASP enzymes and for blocking lectin pathway activation
por: Nagy, Zoltán Attila, et al.
Publicado: (2022)

Herpes simplex encephalitis in adult patients with MASP-2 deficiency
por: Bibert, Stéphanie, et al.
Publicado: (2019)

Mutations of complement lectin pathway genes MBL2 and MASP2 associated with placental malaria
por: Holmberg, Ville, et al.
Publicado: (2012)

Leprosy Association with Low MASP-2 Levels Generated by MASP2 Haplotypes and Polymorphisms Flanking MAp19 Exon 5
por: Boldt, Angelica Beate Winter, et al.
Publicado: (2013)

MASP-3 is the exclusive pro-factor D activator in resting blood: the lectin and the alternative complement pathways are fundamentally linked
por: Dobó, József, et al.
Publicado: (2016)

MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti‐MASP2 antibody narsoplimab
por: Elhadad, S., et al.
Publicado: (2020)

Development and characterization of narsoplimab, a selective MASP-2 inhibitor, for the treatment of lectin-pathway–mediated disorders
por: Dudler, Thomas, et al.
Publicado: (2023)

Unveiling the Great Therapeutic Potential of MASPs as Hemostatic Agents
por: Saad, Ashraf Abdullah
Publicado: (2022)

Flexibility in Mannan-Binding Lectin-Associated Serine Proteases-1 and -2 Provides Insight on Lectin Pathway Activation
por: Nan, Ruodan, et al.
Publicado: (2017)

Adding MASP1 to the lectin pathway—Leprosy association puzzle: Hints from gene polymorphisms and protein levels
por: Weinschutz Mendes, Hellen, et al.
Publicado: (2020)

Highly pathogenic coronavirus N protein aggravates inflammation by MASP-2-mediated lectin complement pathway overactivation
por: Gao, Ting, et al.
Publicado: (2022)

MAp19, the alternative splice product of the MASP2 gene
por: Degn, Søren E., et al.
Publicado: (2011)

Novel MASP1 mutations are associated with an expanded phenotype in 3MC1 syndrome
por: Atik, Tahir, et al.
Publicado: (2015)

Novel MASP-2 inhibitors developed via directed evolution of human TFPI1 are potent lectin pathway inhibitors
por: Szakács, Dávid, et al.
Publicado: (2019)

Targeted deletions of complement lectin pathway genes improve outcome in traumatic brain injury, with MASP-2 playing a major role
por: Mercurio, D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_46op45il09t146duq4mk45l8t2